Aspect Partners’s Helus Pharma HELP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-118
Closed -$780 – 684
2026
Q2
$780 Buy
+118
New +$590 ﹤0.01% 602

Other funds holding HELP

Aspect Partners's HELP Position: Q3 2026 in Review

Aspect Partners sold out of Helus Pharma (HELP) in Q3 2026, closing a stake of 118 shares — an estimated $780 sold.

Aspect Partners first reported a position in HELP in Q2 2026 and held it in 1 quarter. The position peaked at $780 in Q2 2026. 110 funds tracked by Wall St. Rank hold HELP as of Q3 2026.

  • Aspect Partners reported no remaining Helus Pharma position as of Q3 2026 after selling out during the quarter.
  • Aspect Partners sold 118 Helus Pharma shares in Q3 2026, an estimated $780.
  • Aspect Partners first reported a position in Helus Pharma in Q2 2026 and held it in 1 quarter.
  • Aspect Partners's Helus Pharma position peaked at $780 in Q2 2026.
  • 110 funds tracked by Wall St. Rank held Helus Pharma as of Q3 2026.

Based on Aspect Partners's 13F filing for Q3 2026, filed 20 Oct 2026.